POLE and colorectal carcinoma: Further studies on POLE mutations in CRC should incorporate a larger cohort from multiple clinical centers to determine its prevalence in clinical settings, confirm its propensity for early age occurrence and poorer histological grade, and assess its response to immunotherapy regimens.